{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:31:12Z","timestamp":1781152272535,"version":"3.54.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A 77-year-old Japanese man with disseminated Mycobacterium avium complex (MAC) disease due to anti-interferon-gamma autoantibodies received rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) chemotherapy because of non-Hodgkin lymphoma complication. The hepatobiliary nodules due to MAC resolved with R-CHOP and multidrug antimycobacterial treatment. R-CHOP could serve as an alternative adjunctive therapy for patients with anti-interferon-gamma autoantibodies.<\/jats:p>","DOI":"10.1093\/ofid\/ofab181","type":"journal-article","created":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T14:10:51Z","timestamp":1618063851000},"source":"Crossref","is-referenced-by-count":8,"title":["R-CHOP Chemotherapy for Disseminated <i>Mycobacterium avium<\/i> Complex Disease due to Anti-Interferon-Gamma Autoantibodies: A Case Report"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-6138","authenticated-orcid":false,"given":"Shunsuke","family":"Uno","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Sainokuni Higashiomiya Medical Center, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9057-1127","authenticated-orcid":false,"given":"Takuro","family":"Sakagami","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6181-4284","authenticated-orcid":false,"given":"Ho","family":"Namkoong","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0767-3561","authenticated-orcid":false,"given":"Sho","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9398-9599","authenticated-orcid":false,"given":"Yoshifumi","family":"Uwamino","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-7450","authenticated-orcid":false,"given":"Naoki","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,10]]},"reference":[{"key":"2021070723370893200_CIT0001","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3201\/eid2206.151860","article-title":"Interferon-\u03b3 autoantibodies as predisposing factor for nontuberculous mycobacterial infection","volume":"22","author":"Valour","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2021070723370893200_CIT0002","doi-asserted-by":"crossref","first-page":"e3927","DOI":"10.1097\/MD.0000000000003927","article-title":"Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-\u03b3 autoantibodies and disseminated nontuberculous mycobacterial infections","volume":"95","author":"Chi","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2021070723370893200_CIT0003","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"2021070723370893200_CIT0004","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/cid\/cix996","article-title":"Clinical significance of interferon-\u03b3 neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease","volume":"66","author":"Aoki","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2021070723370893200_CIT0005","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1182\/blood-2011-12-395707","article-title":"Anti-CD20 (rituximab) therapy for anti-IFN-\u03b3 autoantibody-associated nontuberculous mycobacterial infection","volume":"119","author":"Browne","year":"2012","journal-title":"Blood"},{"key":"2021070723370893200_CIT0006","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/cid\/cit809","article-title":"Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-\u03b3 autoantibody","volume":"58","author":"Czaja","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021070723370893200_CIT0007","doi-asserted-by":"crossref","first-page":"XXX\u2013XX","DOI":"10.1093\/ofid\/ofaa035","article-title":"Prospective pilot study of cyclophosphamide as an adjunct treatment in patients with adult-onset immunodeficiency associated with anti-interferon-gamma autoantibodies","volume":"7","author":"Laisuan","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2021070723370893200_CIT0008","first-page":"ciaa1086.","article-title":"Daratumumab (anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-IFN-gamma autoantibodies","author":"Ochoa","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021070723370893200_CIT0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.nmni.2018.10.001","article-title":"First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti-interferon-gamma autoantibodies","volume":"27","author":"Namkoong","year":"2019","journal-title":"New Microbes New Infect"},{"key":"2021070723370893200_CIT0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jiac.2013.08.003","article-title":"Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients","volume":"20","author":"Shima","year":"2014","journal-title":"J Infect Chemother"},{"key":"2021070723370893200_CIT0011","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1182\/blood-2018-04-842559","article-title":"Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?","volume":"132","author":"Natkunam","year":"2018","journal-title":"Blood"},{"key":"2021070723370893200_CIT0012","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s10875-013-9907-0","article-title":"B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency","volume":"33","author":"Bax","year":"2013","journal-title":"J Clin Immunol"},{"key":"2021070723370893200_CIT0013","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jpeds.2003.11.012","article-title":"HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency","volume":"144","author":"Camcioglu","year":"2004","journal-title":"J Pediatr"},{"key":"2021070723370893200_CIT0014","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/jmg.2009.072108","article-title":"Multiple cutaneous squamous cell carcinomas in a patient with interferon gamma receptor 2 (IFN gamma R2) deficiency","volume":"47","author":"Toyoda","year":"2010","journal-title":"J Med Genet"},{"key":"2021070723370893200_CIT0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000449251","article-title":"Influence of R-CHOP therapy on immune system restoration in patients with B-cell lymphoma","volume":"91","author":"Ito","year":"2016","journal-title":"Oncology"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofab181\/37016931\/ofab181.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/6\/ofab181\/38487791\/ofab181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/6\/ofab181\/38487791\/ofab181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T02:13:12Z","timestamp":1625710392000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofab181\/6220041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,10]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofab181","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,4,10]]},"article-number":"ofab181"}}